Revance Therapeutics (RVNC) P/E (2014 - 2026)
Revance Therapeutics (RVNC) P/E from Mar 31, 2014 to Jul 21, 2026. The TTM Revance Therapeutics (RVNC) P/E is -1.86. You can export chart.
P/E
Annual P/E change of Revance Therapeutics (RVNC)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.86 | N/A |
| 2025 | -1.86 | +20.07% |
| 2024 | -1.55 | -8.77% |
| 2023 | -1.70 | -63.90% |
| 2022 | -4.70 | +20.36% |
| 2021 | -3.91 | -31.64% |
| 2020 | -5.71 | +30.71% |
| 2019 | -4.37 | -14.29% |
| 2018 | -5.10 | -45.62% |
| 2017 | -9.38 | +41.94% |
| 2016 | -6.61 | -40.39% |
| 2015 | -11.09 | +158.53% |
| 2014 | -4.29 | N/A |
Comparison Revance Therapeutics (RVNC) P/E with competitors
Revance Therapeutics (RVNC) P/E is -1.86.